FeesSafety
Pluang+

Fidelis 100 Index earns Gold certification for Catholic values alignment in Inspire's ETF.

Market News
05 May 2026, 17:52 WIB
PRNewsWire
View Source
Bullish
Fidelis 100 Index earns Gold certification for Catholic values alignment in Inspire's ETF.

The Fidelis 100 Index, which underpins the Inspire Fidelis Multi Factor ETF (FDLS), has received Gold certification from Altum Faithful Investing for aligning with the Social Doctrine of the Catholic Church. This certification confirms that the index maintains a disciplined, rules-based investment approach while adhering to Catholic principles. The ETF combines faith-based values with multi-factor investment strategies, offering investors a unique option that integrates religious convictions with evidence-based portfolio construction. Inspire Investing continues to expand its lineup of biblically responsible ETFs, supporting faith-aligned investing with charitable contributions through its Give50 Program.

More News

Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...

Market News
Bearish
31 minutes ago
Heineken repurchases 9.5 million shares worth €679 million in latest buyback tranche

Heineken repurchases 9.5 million shares worth €679 million in latest buyback tranche

Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...

Company Fundamentals
Neutral
31 minutes ago
Alvotech to present at multiple investor conferences in November 2026.

Alvotech to present at multiple investor conferences in November 2026.

Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...

Market News
Neutral
31 minutes ago
Alvotech to present at multiple investor conferences in November 2026

Alvotech to present at multiple investor conferences in November 2026

Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...

Market News
Neutral
31 minutes ago
Alvotech to present at four major investor conferences in November across Europe.

Alvotech to present at four major investor conferences in November across Europe.

Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...

Market News
Neutral
31 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App